within Pharmacolibrary.Drugs.ATC.V;

model V09AA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 6.166666666666666e-06,
    adminDuration  = 600,
    adminMass      = 740 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00124,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00037,
    k12             = 2.16,
    k21             = 2.16
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V09AA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Technetium (99mTc) exametazime, also known as 99mTc-HMPAO, is a radiopharmaceutical agent used primarily in nuclear medicine for cerebral perfusion imaging, most notably for the detection of cerebral blood flow in patients with suspected stroke, epilepsy, dementia, or other cerebrovascular conditions. It is currently approved and widely used for brain imaging in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are based on data from healthy adult subjects following intravenous administration.</p><h4>References</h4><ol><li><p>Andersen, AR (1989). 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow. <i>Cerebrovascular and brain metabolism reviews</i> 1(4) 288–318. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2701656/&quot;>https://pubmed.ncbi.nlm.nih.gov/2701656</a></p></li><li><p>Goins, B, et al., &amp; Klipper, R (1996). Blood-pool imaging using technetium-99m-labeled liposomes. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 37(8) 1374–1379. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8708778/&quot;>https://pubmed.ncbi.nlm.nih.gov/8708778</a></p></li><li><p>Suzuki, C, et al., &amp; Magata, Y (2017). Quantitation of rat cerebral blood flow using . <i>Nuclear medicine and biology</i> 47 19–22. DOI:<a href=&quot;https://doi.org/10.1016/j.nucmedbio.2016.12.006&quot;>10.1016/j.nucmedbio.2016.12.006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28063322/&quot;>https://pubmed.ncbi.nlm.nih.gov/28063322</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V09AA01;
